Morgan Stanley cautious on GRAIL stock despite $100B market …

1 day ago · On Wednesday, Morgan Stanley (NYSE:MS) began coverage on GRAIL, Inc. (NASDAQ:GRAL), assigning an Equalweight rating to the stock with a price target of $16.00. …

CouponFollow Extension

$100
OFF

Morgan Stanley Cautious On GRAIL Stock Despite $100B Market …

1 day from now

1 day ago · On Wednesday, Morgan Stanley (NYSE:MS) began coverage on GRAIL, Inc. (NASDAQ:GRAL), assigning an Equalweight rating to the stock with a price target of $16.00. …

investing.com

$100
OFF

Morgan Stanley Cautious On GRAIL Stock Despite $100B Market …

1 day from now

1 day ago · On Wednesday, Morgan Stanley (NYSE: MS) began coverage on GRAIL, Inc. (NASDAQ:GRAL), assigning an Equalweight rating to the stock with a price target of …

investing.com

$16.00
OFF

Morgan Stanley Starts GRAIL, Inc. (GRAL) At Equalweight

1 day from now

1 day ago · Morgan Stanley analyst Tejas Savant initiates coverage on GRAIL, Inc. (NASDAQ: GRAL) with a Equalweight rating and a price target of $16.00.The analyst comments: "GRAIL …

streetinsider.com

$100
OFF

Grail 1st-Mover Advantage Faces Regulatory Hurdles In Multi …

1 day from now

17 hours ago · -- Grail's innovative approach positions its as a first-mover in the $100 billion total addressable market for multi-cancer early detection, but challenges include navigating …

marketscreener.com

47%
OFF

Morgan Stanley Sets Illumina Stock Target, Rates Equalweight On …

1 day from now

Despite the cautious outlook from Morgan Stanley, Illumina has shown a strong return over the last year, with a 58.47% price total return as of the latest data. This aligns with the analyst's ...

investing.com

$14.79
OFF

Grail Stock Price Today (NASDAQ: GRAL) Quote, Market Cap, Chart ...

1 day from now

Nov 20, 2024 · GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference. ... GRAL) Grail stock price per share is $14.79 today (as of Nov 19, 2024). What …

wallstreetzen.com

5%
OFF

North New Jersey (Newark/Jersey City) Real Estate Market Reports

1 day from now

Oct 10, 2024 · Download New Jersey Office Market 3Q24. New Jersey Industrial Market. The vacancy rate increased by 20 basis points quarter-over-quarter to 5.5% in the third quarter of …

nmrk.com

FAQs about Morgan Stanley cautious on GRAIL stock despite $100B market … Coupon?

Are Morgan Stanley stock recommendations accurate?

(From Insiders Exposed) This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Morgan Stanley. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. ...

What happened to Grail's stock price?

Shares of Grail fell as much as 11.7% in their market debut on Tuesday after being spun out of gene-sequencing company Illumina. Grail CEO Bob Ragusa joins CNBC's 'Squawk Box' to discuss the company's debut on the Nasdaq, how Grail is innovating early cancer detection, and more. ...

Where can I buy Grail stock?

Shares of GRAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Grail own? Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. ...

Why did GRAIL stock start trading on NASDAQ?

GRAIL shares started trading on Nasdaq after a spin-off from Illumina due to regulatory scrutiny from the EU over their merger. The company offers the Galleri blood test for early cancer detection. Shares of Grail fell as much as 11.7% in their market debut on Tuesday after being spun out of gene-sequencing company Illumina. ...

Why has Tejas Savant rated GRAIL Inc (Grail) a hold?

Tejas Savant has given his Hold rating due to a combination of factors surrounding GRAIL Inc’s current market position and future prospects. The company’s Galleri test has significant potential in early cancer detection, addressing a crucial unmet need. ...

Is Grail a Biotech stock?

The world of biotech stocks got a new member today. Grail (NASDAQ: GRAL) has successfully completed its spinoff from industry leader Illumina (NASDAQ: ILMN). Previously, Grail had functioned as the company’s cancer-testing unit. ...